Mesalazine granules (mesalazine extended-release granules) and mesalazine (enteric-coated) tablets are both used to treat inflammatory bowel disease, the effect varies from person to person, it is not possible to judge which one is better, and you should choose the right drug under the guidance of your doctor. The main ingredient of both mesalazine extended-release granules and mesalazine enteric-coated tablets is mesalazine, which belongs to the 5-aminosalicylic acid class of drugs with anti-inflammatory effects, and is mainly applicable to the treatment of ulcerative colitis and Crohn’s disease. The difference between these two drugs is mainly in the dosage form, the specific effect of the drug needs to take into account the individual variability of the user, this difference makes the two drugs have their own suitable population, so it can not be clearly stated that which drug dosage form of the use of the effect is better. Nausea, headache, dizziness and other adverse reactions may occur after use. Note that mesalazine drugs should be contraindicated in people who are allergic to salicylic acid drugs and excipients of this product, pregnant and lactating women. Use with caution in patients with hepatic and renal insufficiency. Specific medication should be carried out under the guidance of a specialist physician, and should not be used without authorization.